Levels of Circulating Fibroblast Growth Factor 23 (FGF23) and Prognosis in Cancer Patients with Bone Metastases

The fibroblast growth factor (FGF) signaling pathway plays a key role in tumorigenesis and is recognized as a potential therapeutic target. In this study, the authors aimed to assess the impact of serum FGF23 levels in the prognosis of patients with cancer and bone metastases from solid tumors. A co...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansinho, André, Ferreira, Arlindo R., Casimiro, Sandra, Alho, Irina, Vendrell, Inês, Costa, Ana Lúcia, Sousa, Rita, Abreu, Catarina, Pulido, Catarina, Macedo, Daniela, Pacheco, Teresa R., Correia, Lurdes, Costa, Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387099/
https://www.ncbi.nlm.nih.gov/pubmed/30736285
http://dx.doi.org/10.3390/ijms20030695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387099/
https://www.ncbi.nlm.nih.gov/pubmed/30736285
http://dx.doi.org/10.3390/ijms20030695

Ejemplares similares